πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 115 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10954287

Ras binding peptides and methods of use

RA PHARMACEUTICALS, INC. Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918691

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10835574

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10729651

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10709665

Zinc meloxicam complex microparticle multivesicular liposome formulations and processes fo

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10675245

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10617642

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. Β· Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10610486

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10588936

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10562934

Modulation of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10435438

Modulation of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398648

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10328115

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10272132

Peptide and peptidomimetic inhibitors

RA PHARMACEUTICALS, INC. Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10208089

Modulation of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10123974

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10106579

Modulation of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10045941

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10028911

Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (D

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000456

Polycyclic compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9999650

Peptide and peptidomimetic inhibitors

RA PHARMACEUTICALS, INC. Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974744

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9937222

Modulators of complement activity

RA PHARMACEUTICALS, INC. Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9849109

Autotaxin inhibitors and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted